CPH:CC - Cipher Pharmaceuticals Schedules Q1 2025 Earnings Release and Conference Call

Canada NewsWire

MISSISSAUGA, ON , May 2, 2025 /CNW/ - Cipher Pharmaceuticals Inc. (TSX: CPH) (OTCQX: CPHRF) (" Cipher " or the " Company ") today announced that it will release its financial results for the first quarter of 2025 after the market close on Thursday, May 8, 2025 . The Company will also hold a conference call on Friday, May 9, 2025 at 8:30am ET to discuss the results and corporate developments.

CONFERENCE CALL DETAILS

About Cipher Pharmaceuticals Inc.

Cipher Pharmaceuticals (TSX: CPH) (OTCQX: CPHRF) is a specialty pharmaceutical company with a robust and diversified portfolio of commercial and early to late-stage products, mainly in dermatology. Cipher acquires products that fulfill unmet medical needs, manages the required clinical development and regulatory approval process, and currently markets those products in Canada , the U.S., and South America . For more information, visit www.cipherpharma.com .

SOURCE Cipher Pharmaceuticals Inc.

View original content: http://www.newswire.ca/en/releases/archive/May2025/02/c5412.html